Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Change in Working Capital (2017 - 2019)

InflaRx's Change in Working Capital history spans 3 years, with the latest figure at $2.6 million for Q4 2019.

  • On a quarterly basis, Change in Working Capital changed N/A to $2.6 million in Q4 2019 year-over-year; TTM through Dec 2019 was $2.6 million, a N/A change, with the full-year FY2024 number at $5.5 million, up 25.56% from a year prior.
  • Change in Working Capital hit $2.6 million in Q4 2019 for InflaRx, up from $189757.7 in the prior quarter.
  • Over the last five years, Change in Working Capital for IFRX hit a ceiling of $2.6 million in Q4 2019 and a floor of $189757.7 in Q2 2018.
  • Historically, Change in Working Capital has averaged $1.0 million across 3 years, with a median of $227244.5 in 2017.